华熙生物：国寿成达拟减持不超2%股份

Core Viewpoint - Guoshou Chengda plans to reduce its holdings in Huaxi Biological through centralized bidding and block trading, with a maximum reduction of 9.6336 million shares, accounting for no more than 2% of the company's total share capital [1] Group 1 - Guoshou Chengda's reduction plan involves a total of up to 9.6336 million shares [1] - The proposed reduction represents a maximum of 2% of Huaxi Biological's total share capital [1]